Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-09-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328721000390 |
| _version_ | 1819128707853320192 |
|---|---|
| author | Jorge R. Georgakopoulos, MD Tina Felfeli, MD Aaron M. Drucker, MD, ScM, FRCPC Christine E. Jo, BSc Vincent Piguet, MD, PhD, FRCP Jensen Yeung, MD, FRCPC |
| author_facet | Jorge R. Georgakopoulos, MD Tina Felfeli, MD Aaron M. Drucker, MD, ScM, FRCPC Christine E. Jo, BSc Vincent Piguet, MD, PhD, FRCP Jensen Yeung, MD, FRCPC |
| author_sort | Jorge R. Georgakopoulos, MD |
| collection | DOAJ |
| first_indexed | 2024-12-22T08:32:06Z |
| format | Article |
| id | doaj.art-72bdc808dcdc434aa81a9ce1d841be32 |
| institution | Directory Open Access Journal |
| issn | 2666-3287 |
| language | English |
| last_indexed | 2024-12-22T08:32:06Z |
| publishDate | 2021-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD International |
| spelling | doaj.art-72bdc808dcdc434aa81a9ce1d841be322022-12-21T18:32:28ZengElsevierJAAD International2666-32872021-09-0146769Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective studyJorge R. Georgakopoulos, MD0Tina Felfeli, MD1Aaron M. Drucker, MD, ScM, FRCPC2Christine E. Jo, BSc3Vincent Piguet, MD, PhD, FRCP4Jensen Yeung, MD, FRCPC5Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, CanadaDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, CanadaFaculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, CanadaDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Probity Medical Research Inc, Waterloo, Ontario, Canada; Correspondence to: Jensen Yeung, MD, FRCPC, Department of Dermatology, Women's College Hospital, 76 Grenville St, Fifth Floor, Toronto, Ontario M5S 1B2, Canadahttp://www.sciencedirect.com/science/article/pii/S2666328721000390adverse eventatopic dermatitisdrug survivaldupilumabefficacysafety |
| spellingShingle | Jorge R. Georgakopoulos, MD Tina Felfeli, MD Aaron M. Drucker, MD, ScM, FRCPC Christine E. Jo, BSc Vincent Piguet, MD, PhD, FRCP Jensen Yeung, MD, FRCPC Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study JAAD International adverse event atopic dermatitis drug survival dupilumab efficacy safety |
| title | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_full | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_fullStr | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_full_unstemmed | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_short | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_sort | two year efficacy safety and drug survival of dupilumab for atopic dermatitis a real world canadian multicenter retrospective study |
| topic | adverse event atopic dermatitis drug survival dupilumab efficacy safety |
| url | http://www.sciencedirect.com/science/article/pii/S2666328721000390 |
| work_keys_str_mv | AT jorgergeorgakopoulosmd twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT tinafelfelimd twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT aaronmdruckermdscmfrcpc twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT christineejobsc twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT vincentpiguetmdphdfrcp twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT jensenyeungmdfrcpc twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy |